MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson’s disease

    S.B. Koh, S.H. Kang, H.M. Lee, W.K. Seo, J.H. Kim (Seoul, Korea)

    Objective: We investigated the relationship between olfactory impairment, REM sleep behavior disorders (RBD), initial cognitive performance and motor phenotype in Parkinson's disease (PD). Background: Olfactory…
  • 2016 International Congress

    Postural and nonmotor disturbances in Parkinson’s disease

    A. Pilipovich, V. Golubev, G. Ptimat (Moscow, Russia)

    Objective: To investigate postural impairments (PI) and their interrelation with non-motor symptoms in patients with Parkinson's disease (PD). Background: PI mechanisms are only partially known.…
  • 2016 International Congress

    Cognitive impairment in Huntington’s disease

    N. Kamble, N. Netravathi, K. Kumar, S. Jain, P.K. Pal (Bangalore, India)

    Objective: The present study was done to assess cognitive impairment in HD patients using a neuropsychological battery and to correlate with clinical severity and CAG…
  • 2016 International Congress

    Corpus callosum thickness and area in Parkinson’s disease

    I.O. Bledsoe, D. Merkitch, G. Stebbins, B. Bernard, J.G. Goldman (Chicago, IL, USA)

    Objective: To evaluate corpus callosum thickness and area in Parkinson's disease (PD) subjects and the relationship of these measures with cognitive impairment. Background: Many PD…
  • 2016 International Congress

    Cognitive and behavioral problems in children and adolescents with myoclonus dystonia

    M.A. Coenen, H. Eggink, H. van den Berg, J.M. Spikman, M.A. Tijssen (Groningen, Netherlands)

    Objective: To compare the neuropsychological and behavioral profile of A) children and adolescents with myoclonus dystonia (MD) to a healthy control group and B) MD…
  • 2016 International Congress

    Cerebrospinal fluid biomarkers in Parkinson’s disease and associated cognitive impairment

    M. Delgado-Alvarado, B. Gago, A. Gorostidi, H. Jiménez-Urbieta, J. Ruiz-Martínez, A. Bergaretxe-Yarza, J.F. Martí-Massó, P. Martínez-Lage, A. Izagirre, A. Oregi, L. Sepúlveda, M.C. Rodríguez-Oroz (San Sebastián, Spain)

    Objective: Our aim is to assess CSF levels of amyloid-β1-42 (Aβ1-42), T-Tau, threonine-181 phosphorilated tau (P-Tau) and α-synuclein (α-syn) as well as different ratios of…
  • 2016 International Congress

    Dyskinesias-reduced-self-awareness and theory of mind in Parkinson’s disease: A novel frame of interpretation

    S. Palermo, M. Amanzio, M. Zibetti, L. Lopiano (Turin, Italy)

    Objective: To analyze the existence of a relationship between Dyskinesias-reduced-self-awareness (DRSA) and abilities related to cognitive and affective Theory of Mind (ToM), which may represent…
  • 2016 International Congress

    Cognitive and psychiatric outcome 3 years after bilateral deep brain stimulation of the globus pallidus pars interna versus subthalamic nucleus for Parkinson’s disease

    J.A. Boel, V.J.J. Odekerken, G.J. Geurtsen, B.A. Schmand, M. Figee, R.J. de Haan, P. van den Munckhof, P.R. Schuurman, R.M.A. de Bie, The NSTAPS Study Group (Amsterdam, Netherlands)

    Objective: Comparing cognitive and psychiatric outcome 3 years after bilateral deep brain stimulation (DBS) of the globus pallidus pars interna (GPi) and subthalamic nucleus (STN)…
  • 2016 International Congress

    How do cognitive profiles differ in patients with Parkinson’s disease with cognitive decline in comparison to patients remaining cognitively stable? Preliminary results of a 3 years follow-up study

    A. Meyer, U. Gschwandtner, V. Cozac, F. Hatz, P. Fuhr (Basel, Switzerland)

    Objective: (1) To ascertain the evolution of neuropsychological profile of PD patients with stable cognition (non-converter) in comparison to PD patients with a decline (converters)…
  • 2016 International Congress

    Impulse control disorder in Parkinson’s disease is not related to lower cognitive performance

    J. Marin-Lahoz, R. Fernandez-Bobadilla, J. Pagonabarraga, S. Martinez-Horta, B. Pascual-Sedano, J. Perez-Perez, H. Bejr-Kasem, A. Gironell, J. Kulisevsky (Barcelona, Spain)

    Objective: To compare cognitive performance in patients with and without Impulse Control Disorders (ICD) according to MDS recommendations for Parkinson's disease (PD) Mild Cognitive Impairment…
  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley